Medpace (MEDP) Financial Analysis & Valuation | Quarter Chart

Medpace (MEDP)

MEDP
Price: $446.44
Fair Value: 🔒
🔒score
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical... more
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services... more
Description Shares
Market Cap$12.67BExchangeNASDAQ
SectorHealthcareIndustryMedical - Diagnostics & Research
CountryUSCEOAugust James Troendle
IPO Date2016-08-11CAGR0.2%
Employees5,900Websitewww.medpace.com
Div. Yield—Payout Ratio—
Buy Back Yield11.03%Total Yield11.03%
MEDP chart loading...
Fundamentals Technicals
Enterprise Value$15.61BP/E Ratio29.18
Forward P/E25.67PEG Ratio1.2
P/S Ratio3.89P/B Ratio21.58
P/CF Ratio13.91P/FCF Ratio14.01
EPS$15.3EPS Growth 1Y21.22%
EPS Growth 3Y109.44%EPS Growth 5Y299.74%
Revenue Growth 1Y19.97%Gross Margin0.3%
Operating Margin0.21%Profit Margin0.18%
ROE1.19%ROA0.23%
ROCE0.85%Current Ratio0.74
Quick Ratio0.74Cash Ratio0.37
Debt/Equity0.25Interest Coverage—
Altman Z Score6.68Piotroski Score6

View Medpace financial charts →